Home Genocea

Genocea

In operation
IPO
Vaccine and Immunotherapy Developer
Basic
Enterprise Profile

Basic Information

Genocea is harnessing the power of T cell immunity to develop life-changing vaccines and immunotherapies. Genocea has made significant breakthroughs in the discovery of human vaccines and the development of antigens that induce T cell immunity. This platform greatly reduces the time required to discover vaccine candidates. It uniquely employs a proprietary, high-throughput approach that simulates natural immune responses in the laboratory to comprehensively screen for antigens that offer protection across diverse populations.
Genocea Biosciences, Inc.
Cambridge,Massachusetts,United States of America
51~100 people
January 01, 2006
website.inquiry@genocea.com

Enterprise Profile

Industrial Sector
Immune Cell Therapy Vaccine Formulation Production
Technology
Gene Technology Immunological Techniques Cell Technology
Application Scenarios
Traditional Vaccines (Biological Products for Prevention) Cell and Gene Therapy